Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
8275.95
Change Change %
65.45 0.80%

Updated:05 Aug, 2020, 15:59 PM IST

BSE
8283.35
Change Change %
80.50 0.98%

Updated:05 Aug, 2020, 16:01 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Elara Capital
N/A
27-02-2019 Buy 5972.10 6600.00
N/A
Closed Short (1M)
27-03-2019

Elara Capital Recommends 'Accumulate' On Sanofi India

According to Elara Capital, Sanofi India's portfolio is skewed more towards a high-growing chronic portfolio. The company's top products, such as Lantus, Insuman and Allerga, along with line extensions of Amaryl remain resilient, the brokerage adds.

Top
Listen to the latest songs, only on JioSaavn.com